MERCEDES MAQUEDA ABREU-rekin lankidetzan egindako argitalpenak (22)

2023

  1. Advances in the preclinical characterization of the antimicrobial peptide AS-48

    Frontiers in Microbiology, Vol. 14

2021

  1. Antimicrobial activity of the circular bacteriocin as-48 against clinical multidrug-resistant staphylococcus aureus

    Antibiotics, Vol. 10, Núm. 8

2020

  1. Assessing the effectiveness of AS-48 in experimental mice models of Chagas' disease

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 6, pp. 1537-1545

  2. Role of maltodextrin and inulin as encapsulating agents on the protection of oleuropein during in vitro gastrointestinal digestion

    Food Chemistry, Vol. 310

  3. Synergy of the bacteriocin AS-48 and antibiotics against uropathogenic enterococci

    Antibiotics, Vol. 9, Núm. 9, pp. 1-15

2019

  1. Evolution of the phenolic compounds profile of olive leaf extract encapsulated by spray-drying during in vitro gastrointestinal digestion

    Food Chemistry, Vol. 279, pp. 40-48

  2. Insights into Chagas treatment based on the potential of bacteriocin AS-48

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 10, pp. 1-8

  3. Preclinical studies of toxicity and safety of the AS-48 bacteriocin

    Journal of Advanced Research, Vol. 20, pp. 129-139

2018

  1. Assessing in vitro digestibility of food biopreservative AS-48

    Food Chemistry, Vol. 246, pp. 249-257

  2. Autophagic-related cell death of Trypanosoma brucei induced by bacteriocin AS-48

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 8, Núm. 2, pp. 203-212

  3. Control of Propionibacterium acnes by natural antimicrobial substances: Role of the bacteriocin AS-48 and lysozyme

    Scientific Reports, Vol. 8, Núm. 1

  4. LAB bacteriocins controlling the food isolated (drug-resistant) staphylococci

    Frontiers in Microbiology, Vol. 9, Núm. JUN

  5. Synergy between circular bacteriocin AS-48 and ethambutol against mycobacterium tuberculosis

    Antimicrobial Agents and Chemotherapy, Vol. 62, Núm. 9

2017

  1. Enterocin AS-48 as evidence for the use of bacteriocins as new leishmanicidal agents

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 4

  2. Optimization of genotypic and biochemical methods to profile P. acnes isolates from a patient population

    Journal of Microbiological Methods, Vol. 141, pp. 17-24

2015

  1. The bacteriocin AS-48 requires dimer dissociation followed by hydrophobic interactions with the membrane for antibacterial activity

    Journal of Structural Biology, Vol. 190, Núm. 2, pp. 162-172

2014

  1. Analysis of the promoters involved in enterocin AS-48 expression

    PLoS ONE, Vol. 9, Núm. 3

2012

  1. Antimicrobial characterization and safety aspects of the bacteriocinogenic Enterococcus hirae F420 isolated from Moroccan raw goat milk

    Canadian Journal of Microbiology, Vol. 58, Núm. 5, pp. 596-604

  2. Characterization of functional, safety, and probiotic properties of Enterococcus faecalis UGRA10, a new AS-48-producer strain

    Food Microbiology, Vol. 30, Núm. 1, pp. 59-67

  3. Discovering the bacterial circular proteins: Bacteriocins, cyanobactins, and pilins

    Journal of Biological Chemistry